Press release
Avian Influenza Treatment Market 2025: Key Vaccine Developments, Future Scope, Growth Analysis, Industry Trials
Avian Influenza Treatment Market
DataM Intelligence has published a new research report on "Avian Influenza Treatment Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
United States: Recent Industry Developments
✅ October 2025: USDA expanded antiviral stockpiles and approved next-gen treatments to support rapid response during H5N1 outbreaks.
✅ September 2025: Leading biotech firms advanced mRNA-based therapeutics targeted at highly pathogenic avian influenza strains.
✅ August 2025: New federal funding programs were rolled out to accelerate vaccine development for poultry health and zoonotic risk reduction.
Japan: Recent Industry Developments
✅ October 2025: Japan's Ministry of Agriculture invested in improved antiviral formulations for commercial poultry farms.
✅ September 2025: Japanese pharma companies developed rapid-response vaccines tailored to regional avian influenza strains.
✅ August 2025: Collaborative research between universities and veterinary institutes strengthened early detection and treatment strategies.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/avian-influenza-treatment-market?kb
Recent FDA Approvals
The Philippine FDA approved Volvac B.E.S.T. AI plus ND, the country's first vaccine against avian influenza, as a major boost to its poultry sector and food security efforts. This approved vaccine contains a heat-killed variant protecting against circulating H5N1 strains.
In the US, CSL Seqirus' AUDENZTM (influenza A (H5N1) monovalent vaccine, adjuvanted) remains FDA-approved, indicated for people six months and older at high risk of exposure.
The FDA granted Fast Track Designation in December 2024 to Arcturus Therapeutics' self-amplifying mRNA vaccine candidate ARCT-2304 targeting H5N1, supporting expedited clinical development.
Key Players:
Hoffmann-La Roche Ltd, GSK plc, CSL, Boehringer Ingelheim International GmbH, Ceva, Zoetis Services LLC, Merck & Co., Inc
Recent Clinical Trials
Traws Pharma completed Phase I clinical trials of tivoxavir marboxil, a single-dose oral antiviral drug candidate for treating/preventing H5N1 avian influenza. Safety, tolerability, and pharmacokinetics were promising, supporting further development.
Arcturus Therapeutics initiated Phase 1 trial of their sa-mRNA H5N1 vaccine in late 2024, showing early results of immune response provocation, reflecting progress in mRNA vaccine platforms for avian influenza.
Phase 1 intranasal vaccine trials against H5 avian flu showed broad immune responses, advancing alternative vaccine delivery methods aimed at mucosal immunity.
Growth Forecast Projected:
The Global Avian Influenza Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Avian Influenza Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=avian-influenza-treatment-market?kb
Key Segments:
By Virus Strain: (H5N1, H7N9, H10N8, H5N6, H9N2, H6N1, Others)
By Treatment Type: (Antiviral Drugs, Vaccines, Antibiotics, Immunoglobulins, Others)
By End-User: (Hospitals & Clinics, Government Health Agencies, Research Institutes, and Others)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Avian Influenza Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Avian Influenza Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/avian-influenza-treatment-market?kb
Latest Vaccine Introductions
Zoetis received conditional licensure for an updated poultry vaccine targeting H5 subtype avian influenza outbreak strains, based on heat-killed H5N2 virus conferring immunity against H5N1.
New research is advancing universal avian influenza vaccine candidates capable of protecting against multiple variants in a single shot, a promising step to address rapidly evolving H5 subtype viruses worldwide
Get 2-Day Free Trial + 50% OFF DataM Subscription@: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Avian Influenza Treatment Market 2025: Key Vaccine Developments, Future Scope, Growth Analysis, Industry Trials here
News-ID: 4278067 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Food Sweeteners Market Size to Hit US$109.9 Billion by 2031, Expanding at 2.9% C …
Leander, Texas and Tokyo, Japan - Nov 19, 2025
According to DataM Intelligence, the global food sweeteners market reached US$87.5 billion in 2022 and is expected to reach US$109.9 billion by 2031, growing with a CAGR of 2.9% during the forecast period 2024-2031. This steady growth is propelled by increasing health consciousness among consumers, rising prevalence of diabetes and obesity, growing demand for low-calorie food products, stringent regulations on sugar…
Global Bio-Based Packaging Market Projected to Grow at 8.5% CAGR by 2033, Suppor …
Leander, Texas and TOKYO, Japan - The Global Bio-Based Packaging Market was valued at US$1.90 Billion in 2024 and is projected to reach US$3.95 Billion by 2033, expanding at a strong CAGR of 8.5% from 2025 to 2033.
The market is growing due to increasing demand for sustainable and eco-friendly packaging solutions, supported by stringent government regulations on single-use plastics. Rising consumer awareness, corporate sustainability goals, and expanding adoption across food,…
U.S. Electric Vehicle (EV) Connectors Market to Reach USD 56.32 Million by 2032, …
The U.S. Electric Vehicle (EV) Connectors Market was valued at US$ 12.58 million in 2024 and is projected to reach US$ 56.32 million by 2032, growing at a CAGR of 29.0% during the forecast period.
The market is strategically positioned at the center of EV infrastructure growth, driven by rapid expansion of public and residential charging networks, increasing adoption of EVs, and the need for high-performance, reliable connectors. The U.S. leads…
United States Generic Drugs Market is to reach USD 231.69 billion by 2034 - Driv …
Leander, Texas and TOKYO, Japan- The U.S. generic drugs market size was approximately USD 146.04 billion in 2025. It is projected to grow to around USD 231.69 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 5.24% during 2025 to 2034.
Download Free sample report:-https://www.datamintelligence.com/download-sample/generic-drugs-market?pratik
Recent Industry Development in U.S market:
✅ U.S. is one of the largest single-country markets for generic drugs globally.
✅ A USP (U.S. Pharmacopeia)…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
